This GLP 1 receptor agonist blocked the proliferation of MCF-7 BC cells in obese adipose tissue-derived stem cell-conditioned medium, promoted G0/G1 phase arrest, decreased colony formation and the level of inflammatory mediators, blocked leptin (a carcinogenic adipokine) expression, and augmented mRNA levels of adiponectin (an antineoplastic adipokine) [80]. Here, GLP1R is linked to breast cancer.